Search
OraSure Technologies Inc
OSURAdd to Watchlist
4.350USD
+0.030+0.69%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
301.88MMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey 图表Intraday
1m
30m
1h
D
W
M
D
Today
+0.69%
5 Days
-2.47%
1 Month
+4.32%
6 Months
+82.77%
Year to Date
+79.75%
1 Year
+41.23%
Key Figures
4.350Open
4.470High
431.86KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.62%Turnover Ratio
4.320Prev. Close
4.330Low
1.36MTurnover
LossP/E Static
0.96P/B
0.00%Div Yield TTM
-17.94%ROA
4.33052wk High
1.10Volume Ratio
-19.50MNet Profit
69.40MShares
-1.0422EPS TTM
0.99Beta
-21.16%ROE
2.08052wk Low
3.24%Amplitude
42.27%Gross Margin
301.88MMarket Cap
1.08Reward/Risk
3.34%Risk Rate
TradingKey Stock Score of OraSure Technologies Inc
Currency: USD Updated: 2026-07-02Key Insights
OraSure Technologies Inc's fundamentals are relatively very healthy, and its growth potential is significant.Its valuation is considered fairly valued, ranking 55 out of 204 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 5.00.In the medium term, the stock price is expected to trend up.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
OraSure Technologies Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Negative
OraSure Technologies Inc Highlights
StrengthsRisks
OraSure Technologies, Inc. transforms health through actionable insight and decentralizes diagnostics to connect people to healthcare wherever they are. The Company improves the access, quality, and value of healthcare with innovation in effortless tests and sample management solutions. The Company, together with its wholly owned subsidiaries, DNA Genotek Inc. and Sherlock Biosciences, Inc., is engaged in the development, manufacture, and distribution of rapid diagnostic tests and sample collection and stabilization devices designed to discover and detect critical medical conditions. Its portfolio of products is sold globally to clinical laboratories, hospitals, physician’s offices, clinics, public health and community-based organizations, research institutions, government agencies, pharmaceutical companies, and direct consumers. Its products and services include OraQuick ADVANCE Rapid HIV1/2 Antibody Test, OraQuick HIV Self-Test, and Diagnostics Direct Syphilis Health Check.
Undervalued
The company’s latest PE is -4.17, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 65.49M shares, decreasing 13.32% quarter-over-quarter.
Held by ETHSX
Star Investor ETHSX holds 169.02K shares of this stock.
Analyst Rating
Based on
2
analysts
Buy
Current Rating
5.000
Target Price
+15.74%
Upside Space
OraSure Technologies Inc News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
OraSure Technologies Inc Info
OraSure Technologies, Inc. transforms health through actionable insight and decentralizes diagnostics to connect people to healthcare wherever they are. The Company improves the access, quality, and value of healthcare with innovation in effortless tests and sample management solutions. The Company, together with its wholly owned subsidiaries, DNA Genotek Inc. and Sherlock Biosciences, Inc., is engaged in the development, manufacture, and distribution of rapid diagnostic tests and sample collection and stabilization devices designed to discover and detect critical medical conditions. Its portfolio of products is sold globally to clinical laboratories, hospitals, physician’s offices, clinics, public health and community-based organizations, research institutions, government agencies, pharmaceutical companies, and direct consumers. Its products and services include OraQuick ADVANCE Rapid HIV1/2 Antibody Test, OraQuick HIV Self-Test, and Diagnostics Direct Syphilis Health Check.
Ticker SymbolOSUR
CompanyOraSure Technologies Inc
CEOEglinton Manner (Carrie)
Websitehttps://www.orasure.com/
Related Instruments
-0.37%
+1.91%
+3.48%
+5.87%
+2.10%
-0.10%
+4.19%
+5.03%
+4.30%
+0.25%
+3.65%
+4.74%
+2.79%
+2.59%
-3.06%
+3.40%
+3.76%
+1.10%
+0.28%
-2.09%Popular Instruments
52852.900
+10.400 (+0.02%)
29669.900
+358.500 (+1.22%)
7507.800
+36.300 (+0.49%)
14963.000
+160.000 (+1.08%)
69676.000
+1528.000 (+2.24%)
6412.400
+59.600 (+0.94%)
68.683
+0.339 (+0.50%)
308.630
+14.250 (+4.84%)
194.830
-2.750 (-1.39%)
4174.610
+52.700 (+1.28%)
FAQs
What is the current price of OraSure Technologies Inc (OSUR)?
The current price of OraSure Technologies Inc (OSUR) is 4.35.
What is the symbol of OraSure Technologies Inc?
The ticker symbol of OraSure Technologies Inc is OSUR.
What is the 52-week high of OraSure Technologies Inc?
The 52-week high of OraSure Technologies Inc is 4.33.
What is the 52-week low of OraSure Technologies Inc?
The 52-week low of OraSure Technologies Inc is 2.08.
What is the market capitalization of OraSure Technologies Inc?
The market capitalization of OraSure Technologies Inc is 301.88M.
Is OraSure Technologies Inc (OSUR) currently rated as Buy, Hold, or Sell?
According to analysts, OraSure Technologies Inc (OSUR) has an overall rating of Buy, with a price target of 5.00.
What is the Earnings Per Share (EPS TTM) of OraSure Technologies Inc (OSUR)?
The Earnings Per Share (EPS TTM) of OraSure Technologies Inc (OSUR) is -0.94.